Bioresource-derived tannic acid-supported immuno-network in lateral flow immunoassay for sensitive clenbuterol monitoring

Liu, Sijie; Shu, Rui; Nie, Chen; Li, Yuechun; Luo, Xing; Ji, Yanwei; Yin, Xuechi; Sun, Jing; Zhang, Daohong; Wang, Jianlong

doi:10.1016/j.foodchem.2022.132390

Cited by 30 publications

(12 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…To estimate the applications of the VS 2 NS-based LFIA, pork and beef were selected as real samples. We pretreated real samples according to previous studies with some modifications. , These food samples (1 g) were cut into pieces and mixed vigorously with 2 mL of PBS for 10 min after adding trichloroacetic acid (3%). The obtained extract was centrifuged (10,000 rpm, 7 min), and the supernatant liquid was adjusted to a pH value of 7.…”

Section: Methodsmentioning

confidence: 99%

Vanadium Disulfide Nanosheet Boosts Optical Signal Brightness as a Superior Enzyme Label to Improve the Sensitivity of Lateral Flow Immunoassay

et al. 2022

Self Cite

View full text Add to dashboard Cite

The color-enzyme lateral flow immunoassay (LFIA) has attracted widespread attention to expand the detection range and improve sensitivity via amplifying the color signal after catalyzing the substrate. As a kind of layered transition-metal dichalcogenide (TMD), the vanadium disulfide nanosheet (VS2NS) possesses superior peroxidase-like catalytic activity. Here, a VS2NS was applied as an enzyme label in the LFIA to detect 17β-estradiol (E2). Compared to natural horseradish peroxidase, the VS2NS expresses a more prominent enzyme catalytic performance, stability, and adsorption ability. Under optimal conditions, the calculated limit of detection (cLOD) of the VS2NS-based LFIA is 0.065 ng mL–1 for E2, which is sixfold lower than that of the optimized colloidal nanoparticle-based LFIA (cLOD = 0.406 ng mL–1). Besides, the detection linear range of the VS2NS-based LFIA can be widened by 1.5 times after the catalytic reaction. Moreover, the VS2NS-based LFIA exhibits excellent practicability in real sample detection. Simultaneously, this study helps open up the application of the VS2NS in the trace analysis of LFIAs, which can broaden TMDs’ scope of application and better show their properties of color enzymes.

show abstract

Section: Methodsmentioning

confidence: 99%

Vanadium Disulfide Nanosheet Boosts Optical Signal Brightness as a Superior Enzyme Label to Improve the Sensitivity of Lateral Flow Immunoassay

et al. 2022

Self Cite

View full text Add to dashboard Cite

show abstract

“…To verify the analytical performances of CRISPR‐E, the nucleocapsid antigen of SARS‐CoV‐2 was used as a model. The developed CRISPR‐E method showed a high sensitivity for SARS‐CoV‐2 nucleocapsid antigen, achieving a low LOD of 0.16 ng/ml ranging from 0.05 to 5.0 ng/ml (N. Liu et al., 2022 ).…”

Section: Crispr/cas Systems‐based Sars‐cov‐2 Detectionmentioning

confidence: 99%

“…Since its first usage in the pregnancy test in 1970s, LFA has showed its success of the general design and kept almost unchanged (Parolo, de la Escosura‐Muñiz, & Merkoçi, 2013 ; Zhou, Wu, Ding, Huang, & Xiong, 2021 ). Almost all LFA strips rely on capillary forces for moving the sample and reagent along a test strip to produce a detectable signal (Yuechun Li et al., 2022 ; S. Liu, R. Shu, C. Nie, et al., 2022 ). Especially, LFA as a well‐known technology and a popular POC test platform have played a significant role in the control of the COVID‐19 pandemic (S. Liu, R. Shu, J. Ma, et al., 2022 ; Parolo et al., 2020 ; X. Zhang, Li, Wu, Liu, & Wu, 2020 ; Zhou et al., 2021 ).…”

Section: Crispr/cas Systems‐based Sars‐cov‐2 Detectionmentioning

confidence: 99%

Point‐of‐care CRISPR/Cas biosensing technology: A promising tool for preventing the possible COVID‐19 resurgence caused by contaminated cold‐chain food and packaging

et al. 2022

View full text Add to dashboard Cite

The ongoing coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has caused great public health concern and has been a global threat due to its high transmissibility and morbidity. Although the SARS‐CoV‐2 transmission mainly relies on the person‐to‐person route through the respiratory droplets, the possible transmission through the contaminated cold‐chain food and packaging to humans has raised widespread concerns. This review discussed the possibility of SARS‐CoV‐2 transmission via the contaminated cold‐chain food and packaging by tracing the occurrence, the survival of SARS‐CoV‐2 in the contaminated cold‐chain food and packaging, as well as the transmission and outbreaks related to the contaminated cold‐chain food and packaging. Rapid, accurate, and reliable diagnostics of SARS‐CoV‐2 is of great importance for preventing and controlling the COVID‐19 resurgence. Therefore, we summarized the recent advances on the emerging clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system‐based biosensing technology that is promising and powerful for preventing the possible COVID‐19 resurgence caused by the contaminated cold‐chain food and packaging during the COVID‐19 pandemic, including CRISPR/Cas system‐based biosensors and their integration with portable devices (e.g., smartphone, lateral flow assays, microfluidic chips, and nanopores). Impressively, this review not only provided an insight on the possibility of SARS‐CoV‐2 transmission through the food supply chain, but also proposed the future opportunities and challenges on the development of CRISPR/Cas system‐based detection methods for the diagnosis of SARS‐CoV‐2.

show abstract

“… Novel labels used to improve the sensitivity of LFAs. Schematic illustrations showing: ( A ) synthesis of IrO 2 @ PDA and IrO 2 @ PDA-based LFAs, reprinted with permission from [ 68 ], Copyright 2021, American Chemical Society; (( B )-a) preparation of a bioresource-derived PTAN-based immuno-network and (( B )-b) comparison of an indirect probe-based immune network with a traditional direct label format, reprinted with permission from [ 69 ], Copyright 2022, Elsevier; (( C )-a) preparation and surface modifications of hollow Au-Ag NPs and (( C )-b) a schematic illustration of hollow Au-Ag NP-labeled LFAs, reproduced from [ 61 ]; ( D ) Schematic illustration of CuS-NS-based signal amplification, reprinted with permission from [ 70 ], Copyright 2022, Elsevier. …”

Section: Figurementioning

confidence: 99%

“…its sensitivity was 24-fold and 180-fold higher than the LFA based on IrO2 NPs and AuNPs, respectively, with high specificity. Li et al [69] used poly tannic acid nanospheres (PTANs) as a novel marker and proposed an immune network-based indirect labeling system for LFAs supported by bioresource-derived tannic acid (TA) for CLE detection (Figure 4B). The PTANs were synthesized using a formaldehyde-assisted cross-linking strategy.…”

Section: Other Novel Labelsmentioning

confidence: 99%

Paper-Based Fluidic Sensing Platforms for β-Adrenergic Agonist Residue Point-of-Care Testing

et al. 2022

View full text Add to dashboard Cite

The illegal use of β-adrenergic agonists during livestock growth poses a threat to public health; the long-term intake of this medication can cause serious physiological side effects and even death. Therefore, rapid detection methods for β-adrenergic agonist residues on-site are required. Traditional detection methods such as liquid chromatography have limitations in terms of expensive instruments and complex operations. In contrast, paper methods are low cost, ubiquitous, and portable, which has led to them becoming the preferred detection method in recent years. Various paper-based fluidic devices have been developed to detect β-adrenergic agonist residues, including lateral flow immunoassays (LFAs) and microfluidic paper-based analytical devices (μPADs). In this review, the application of LFAs for the detection of β-agonists is summarized comprehensively, focusing on the latest advances in novel labeling and detection strategies. The use of μPADs as an analytical platform has attracted interest over the past decade due to their unique advantages and application for detecting β-adrenergic agonists, which are introduced here. Vertical flow immunoassays are also discussed for their shorter assay time and stronger multiplexing capabilities compared with LFAs. Furthermore, the development direction and prospects for the commercialization of paper-based devices are considered, shedding light on the development of point-of-care testing devices for β-adrenergic agonist residue detection.

show abstract

Bioresource-derived tannic acid-supported immuno-network in lateral flow immunoassay for sensitive clenbuterol monitoring

Cited by 30 publications

References 38 publications

Vanadium Disulfide Nanosheet Boosts Optical Signal Brightness as a Superior Enzyme Label to Improve the Sensitivity of Lateral Flow Immunoassay

Vanadium Disulfide Nanosheet Boosts Optical Signal Brightness as a Superior Enzyme Label to Improve the Sensitivity of Lateral Flow Immunoassay

Point‐of‐care CRISPR/Cas biosensing technology: A promising tool for preventing the possible COVID‐19 resurgence caused by contaminated cold‐chain food and packaging

Paper-Based Fluidic Sensing Platforms for β-Adrenergic Agonist Residue Point-of-Care Testing

Contact Info

Product

Resources

About